Role of visfatin in obesity-induced insulin resistance

doi:10.12998/wjcc.v10.i30.10840

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5771)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

245

WORD

HTML

4122

Figures (1-3)

411

Sum=4809

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

324

Download

638

Sum=962

Oct 26, 2022 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Oct 26, 2022; 10(30): 10840-10851
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.10840

Full Size Figure Download Figure

Figure 1 Visfatin’ s journey from an insulin-mimetic to the enzyme (nicotinamide phosphoribosyltransferase).

Citation: Abdalla MMI. Role of visfatin in obesity-induced insulin resistance. World J Clin Cases 2022; 10(30): 10840-10851
URL: https://www.wjgnet.com/2307-8960/full/v10/i30/10840.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i30.10840